fluconazole/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The use of prophylactic fluconazole was associated with a reduction in the proportion of patients with candidaemia (RR = 0.21, 95% CI = 0.06–0.72, P = 0.01; I2 = 0%) and fungal infections other than lower urinary tract infection (RR = 0.39, 95% CI = 0.24–0.65, P = 0.0003; I2 = 0%), but was associated with no significant difference in hospital mortality (RR = 0.82, 95% CI = 0.62–1.08, P = 0.15; I2 = 7%).”
Quoted verbatim from The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis.. - Study
- meta-analysis
- Dose
- 100 to 800 mg/day
- Population
- Immunocompetent high-risk surgical adult patients in seven randomised trials of prophylactic fluconazole versus placebo; pooled routes (five intravenous, one enteral, one either)
Effect 0.82 risk ratio, 95% CI 0.62 to 1.08
The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis.2005PMID:16280069Industry fundedPermalink
Keep reading
- Everything the graph holds on fluconazole
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45WEK92GG4V8RB7Y41QDQ8Z